MX2011009258A - Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas. - Google Patents

Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas.

Info

Publication number
MX2011009258A
MX2011009258A MX2011009258A MX2011009258A MX2011009258A MX 2011009258 A MX2011009258 A MX 2011009258A MX 2011009258 A MX2011009258 A MX 2011009258A MX 2011009258 A MX2011009258 A MX 2011009258A MX 2011009258 A MX2011009258 A MX 2011009258A
Authority
MX
Mexico
Prior art keywords
cationic oil
water emulsions
oil
emulsions containing
water
Prior art date
Application number
MX2011009258A
Other languages
English (en)
Inventor
Betty Philips
Frederic Lallemand
Jean-Sebastien Garrigue
Original Assignee
Novagali Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novagali Pharma Sa filed Critical Novagali Pharma Sa
Publication of MX2011009258A publication Critical patent/MX2011009258A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a una emulsión catiónica aceite- en-agua coloidal que comprende: - una prostaglandina, - un aceite teniendo un valor de yodo = 2, - uno o más surfactantes incluyendo al menos un compuesto de amonio cuaternario, - agua, en donde la proporción de masa de prostaglandina/suma total de surfactantes está comprendida entre 0.5 y 5. La presente invención también pertenece al uso de dichas emulsiones catiónicas aceite-en-agua para intensificar la estabilidad de dichas prostaglandinas, para el tratamiento e hipertensión ocular y/o glaucoma, para promover el crecimiento de pestañas y/o para tratar hipotricosis de pestañas.
MX2011009258A 2009-03-04 2010-03-04 Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas. MX2011009258A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15735509P 2009-03-04 2009-03-04
EP09305202A EP2228057A1 (en) 2009-03-04 2009-03-04 Cationic oil-in-water emulsions containing prostaglandins and uses thereof
PCT/EP2010/052741 WO2010100218A1 (en) 2009-03-04 2010-03-04 Cationic oil-in-water emulsions containing prostaglandins and uses thereof

Publications (1)

Publication Number Publication Date
MX2011009258A true MX2011009258A (es) 2011-09-27

Family

ID=40627247

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011009258A MX2011009258A (es) 2009-03-04 2010-03-04 Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas.

Country Status (12)

Country Link
US (1) US20110313038A1 (es)
EP (2) EP2228057A1 (es)
JP (1) JP5722803B2 (es)
KR (1) KR101813211B1 (es)
CN (1) CN102341094B (es)
AU (1) AU2010220322B2 (es)
CA (1) CA2754157C (es)
ES (1) ES2453472T3 (es)
HK (1) HK1166609A1 (es)
IL (1) IL214507A (es)
MX (1) MX2011009258A (es)
WO (1) WO2010100218A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2389939A1 (en) * 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
EP2618810B1 (en) 2010-09-21 2016-11-23 S & V Technologies GmbH Cosmetic composition
CN109106606A (zh) * 2013-03-14 2019-01-01 阿勒根公司 包含比马前列素的局部组合物和利用其刺激毛发生长的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578176C (en) * 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
CA2625568C (en) * 2005-10-10 2013-10-08 Novagali Pharma Sa Ophthalmic emulsions containing prostaglandins
CN104224704A (zh) * 2006-03-13 2014-12-24 株式会社·R-技术上野 水性组合物
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
WO2008074885A2 (en) 2006-12-21 2008-06-26 Novagali Pharma Sa Process for manufacturing ophthalmic oil-in-water emulsions
US20090169629A1 (en) * 2008-01-02 2009-07-02 Novagali Pharma Sa Micellar compositions with ophthalmic applications

Also Published As

Publication number Publication date
AU2010220322A1 (en) 2011-09-01
JP2012519665A (ja) 2012-08-30
KR20120010225A (ko) 2012-02-02
CA2754157A1 (en) 2010-09-10
IL214507A0 (en) 2011-09-27
EP2403477B1 (en) 2014-01-15
CA2754157C (en) 2017-06-06
AU2010220322B2 (en) 2015-08-27
HK1166609A1 (en) 2012-11-02
IL214507A (en) 2015-11-30
US20110313038A1 (en) 2011-12-22
EP2228057A1 (en) 2010-09-15
CN102341094B (zh) 2014-09-03
EP2403477B8 (en) 2014-02-26
KR101813211B1 (ko) 2017-12-29
CN102341094A (zh) 2012-02-01
ES2453472T3 (es) 2014-04-07
EP2403477A1 (en) 2012-01-11
JP5722803B2 (ja) 2015-05-27
WO2010100218A1 (en) 2010-09-10

Similar Documents

Publication Publication Date Title
MX2011009256A (es) Emulsiones aceite-en-agua anionicas conteniendo prostaglandinas y usos de las mismas.
MX2011009258A (es) Emulsiones aceite-en-agua cationicas conteniendo prostaglandinas y usos de las mismas.
WO2010138710A3 (en) Topical skin care compositions comprising starch and quaternary ammonium salt
WO2008035246A3 (en) Compositions containing quaternary ammonium compounds
BRPI0607447A2 (pt) solução oftálmica de bimatoprost aprimorada
PL1937212T3 (pl) Emulsje oftalmiczne zawierające prostaglandyny
PH12015501938A1 (en) Ocular formulations for drug-delivery to the posterior segment of the eye
WO2009111418A3 (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
WO2007059888A3 (en) Oil-in-water emulsions based on special emulsifiers
WO2016046848A3 (en) Novel formulation of concentrated natural actives in oil-water microemulsion for hair fall prevention and increase in hair density
EA201491737A1 (ru) Композиции и способы регулирования роста волос
ZA202108950B (en) Oxymetazoline compositions and methods for treating ocular disorders
MX2022003903A (es) Optimizacion del nivel de conservantes para composiciones para el cuidado personal.
RU2012150795A (ru) Композиция для борьбы с заболеваниями растений и ее применение описание
RU2013146223A (ru) Способ изготовления одноразового впитывающего изделия и изделие, изготовленное таким способом
IN2014CN04809A (es)
CN103841968A (zh) 眼睑治疗方法
RU2013146037A (ru) Косметическая композиция в виде эмульсии вода-в-масле
MA29516B1 (fr) Modulateurs d'androgenes
PH12016501901B1 (en) Composition in the form of an oil-in-water emulsion comprising ground white or yellow mustard seed
WO2011124560A3 (en) Hair care compositions
EA201891858A1 (ru) Способ получения эмульсий с небольшими каплями при низком давлении
RU2012124216A (ru) Фармацевтическая комбинация соединения простагландина и nsaid для лечения глаукомы и глазной гипертензии
EA202290013A1 (ru) Средство для усиления роста волос
CO6290691A2 (es) 2-[4-(7-etil-5h-pirrolo[2,3-b]pirazin-6-il)-fenil]-propan-2-ol o una sal farmaceúticamente aceptable o profarmaco del mismo

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: BASF SE